Third, the cognitive impairment induced by ketamine was reversed by PROG and ALLO add-on treatments, and the PGRMC1/EGFR/GLP-1R/PI3K/Akt pathway was upregulated. This evidence concerns the gene GLP1R and Cognitive impairment.